Skip to content
Cefprozil
Cefzil (cefprozil) is a small molecule pharmaceutical. Cefprozil was first approved as Cefzil on 1991-12-23. It is used to treat bacterial infections, bacterial skin diseases, bronchitis, escherichia coli infections, and haemophilus infections amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
stomatognathic diseasesD009057
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cefprozil
Tradename
Company
Number
Date
Products
CEFZILCordenPharmaN-050664 DISCN1991-12-23
2 products, RLD
CEFZILCordenPharmaN-050665 DISCN1991-12-23
2 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
cefprozilANDA2023-02-04
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial infections—D001424A49
bacterial skin diseases—D017192—
bronchitis—D001991J40
escherichia coli infectionsEFO_1001318D004927B96.20
haemophilus infectionsEFO_1001127D006192—
klebsiella infectionsEFO_1001353D007710—
moraxellaceae infectionsEFO_1001072D045828—
otitis mediaEFO_0004992D010033H66.9
pharyngitis—D010612R07.0
proteus infectionsEFO_1001130D011512—
Show 3 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01D: Other beta-lactam antibacterials in atc
— J01DC: Second-generation cephalosporins
— J01DC10: Cefprozil
HCPCS
No data
Clinical
Clinical Trials
5 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C802————2
DiarrheaD003967HP_0002014R19.71————1
Healthy volunteers/patients—1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MicrobiotaD064307————11
Urinary tract infectionsD014552EFO_0003103N39.0————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCEFPROZIL
INNcefprozil
Description
Cefprozil is a semisynthetic, second-generation cephalosporin, with prop-1-enyl and (R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used to treat bronchitis as well as ear, skin and other bacterial infections. It has a role as an antibacterial drug. It is a cephalosporin and a semisynthetic derivative.
Classification
Small molecule
Drug classcephalosporins
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1.O
Identifiers
PDB—
CAS-ID92676-86-3
RxCUI19552
ChEMBL IDCHEMBL3184906
ChEBI ID—
PubChem CID5281006
DrugBankDB01150
UNII ID1M698F4H4E (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 681 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1,178 adverse events reported
View more details